Related Experiment Video
Updated: May 18, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
Cut point validation vs. real-world performance: the ultra-low cut point dilemma
Lindsay Denhoff1, Cansu Dernek2, Liam Heins3
1Bioanalytical Laboratories, ICON plc, Whitesboro, NY, USA.
None:
Cut point determination is a critical component in the development and validation of antidrug antibody (ADA) assays, directly influencing the assessment of immunogenic responses. Removal of analytical and biological outliers from employing Tukey's outlier test may lead to reduced variability and consequently low or ultra-low cut points (ULCPs, defined here as signal-to-noise ratios ≤1.10). Such ULCPs raise concerns about assay reliability and the potential for elevated false-positive rates. To evaluate this, we analyzed ADA studies from two contract research organizations employing ULCPs. Given the heightened assay sensitivity from modern platforms and reagents, our findings indicate that ULCPs do not inherently compromise ADA assay performance or reliability. These results support the continued use of ULCPs when appropriately validated and statistically justified.
Related Concept Videos
Detection of Gross Error: The Q Test
Quantifying and Rejecting Outliers: The Grubbs Test
Difference from Background: Limit of Detection
The LOD indicates the presence or absence...
Upsampling
Cut-off Frequency of BJT
Alpha Cut-Off Frequency: Pertinent to the common-base configuration, the alpha cut-off frequency defines the upper-frequency limit at which the current gain, alpha, remains stable. As...
Receiver Operating Characteristic Plot